IL141056A0 - Protease inhibitors for use in the treatment of psoriasis - Google Patents
Protease inhibitors for use in the treatment of psoriasisInfo
- Publication number
- IL141056A0 IL141056A0 IL14105699A IL14105699A IL141056A0 IL 141056 A0 IL141056 A0 IL 141056A0 IL 14105699 A IL14105699 A IL 14105699A IL 14105699 A IL14105699 A IL 14105699A IL 141056 A0 IL141056 A0 IL 141056A0
- Authority
- IL
- Israel
- Prior art keywords
- psoriasis
- treatment
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP5087A AUPP508798A0 (en) | 1998-08-05 | 1998-08-05 | Method of treating psoriasis |
| PCT/IB1999/001483 WO2000007620A1 (en) | 1998-08-05 | 1999-08-05 | Protease inhibitors for use in the treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141056A0 true IL141056A0 (en) | 2002-02-10 |
Family
ID=3809320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14105699A IL141056A0 (en) | 1998-08-05 | 1999-08-05 | Protease inhibitors for use in the treatment of psoriasis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6288025B1 (de) |
| EP (1) | EP1102599A4 (de) |
| JP (1) | JP2002522396A (de) |
| KR (1) | KR20010072278A (de) |
| CN (1) | CN1322138A (de) |
| AU (1) | AUPP508798A0 (de) |
| CA (1) | CA2339485A1 (de) |
| IL (1) | IL141056A0 (de) |
| NO (1) | NO20010569L (de) |
| WO (1) | WO2000007620A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ380699A0 (en) * | 1999-11-02 | 1999-11-25 | Biotech Australia Pty Limited | Protease inhibitors as modulators of periodontal wound healing |
| WO2004045634A1 (en) * | 2002-11-20 | 2004-06-03 | Arriva-Prometic Inc. | Composition and method for treating inflammatory diseases using protease inhibitors |
| SE531785C2 (sv) * | 2006-12-05 | 2009-08-04 | Bengt-Sture Ershag | Anläggning för återvinning av kol och kolväteföreningar genom pyrolys |
| KR101503958B1 (ko) * | 2007-08-31 | 2015-03-18 | 디에스엠 아이피 어셋츠 비.브이. | 미용 및/또는 피부과학적 용도의 4-아미디노 벤질아민 |
| BRPI0906167A2 (pt) * | 2008-01-21 | 2018-05-22 | Dermadis S A | uso de inibidor de serina protease no tratamento de doenças de pele. |
| US10377818B2 (en) | 2015-01-30 | 2019-08-13 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating glioma |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290762A (en) * | 1986-12-24 | 1994-03-01 | John Lezdey | Treatment of inflammation |
| DE3829523A1 (de) * | 1988-08-31 | 1990-03-01 | Behringwerke Ag | Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression |
| DK0462207T3 (da) | 1989-03-06 | 2001-06-18 | Univ Texas | t-Pa mutanter resistente mod deres respektive inhibitorer |
| US5304482A (en) | 1989-03-06 | 1994-04-19 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| US5550042A (en) | 1989-03-06 | 1996-08-27 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
| CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
| ES2104610T3 (es) | 1989-09-05 | 1997-10-16 | Biotech Australia Pty Ltd | Proceso para la preparacion de pai-2. |
| US5204807A (en) | 1989-10-04 | 1993-04-20 | Pitney Bowes Plc. | Postage meter housing arrangement having RF and electromagnetic induction shielding |
| DE69031271T2 (de) | 1989-12-20 | 1998-02-26 | Biotech Australia Pty Ltd | Varianten von pai-2 |
| US5242801A (en) | 1990-08-06 | 1993-09-07 | University Of Iowa Research Foundation | Diagnosing malignant hyperthermia susceptibility by detection of abnormal proteolytic enzyme digestion fragments of the ryanodine receptor |
| JPH06279316A (ja) * | 1993-03-25 | 1994-10-04 | Shiseido Co Ltd | 皮膚外用剤 |
| US5403482A (en) | 1993-10-12 | 1995-04-04 | Gelman Sciences Inc. | Self-supporting, pleated, spirally wound filter and the corresponding process of making |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| US5939525A (en) * | 1995-03-27 | 1999-08-17 | Viron Therapeutics, Inc. | Methods of treating inflammation and compositions therefor |
| US6344189B1 (en) * | 1998-04-01 | 2002-02-05 | Biotech Australia Pty., Ltd. | Use of protease inhibitors for treating skin wounds |
-
1998
- 1998-08-05 AU AUPP5087A patent/AUPP508798A0/en not_active Abandoned
-
1999
- 1999-08-05 CA CA002339485A patent/CA2339485A1/en not_active Abandoned
- 1999-08-05 CN CN99811799A patent/CN1322138A/zh active Pending
- 1999-08-05 EP EP99938478A patent/EP1102599A4/de not_active Withdrawn
- 1999-08-05 KR KR1020017001554A patent/KR20010072278A/ko not_active Application Discontinuation
- 1999-08-05 WO PCT/IB1999/001483 patent/WO2000007620A1/en not_active Application Discontinuation
- 1999-08-05 JP JP2000563303A patent/JP2002522396A/ja active Pending
- 1999-08-05 US US09/368,164 patent/US6288025B1/en not_active Expired - Fee Related
- 1999-08-05 IL IL14105699A patent/IL141056A0/xx unknown
-
2001
- 2001-02-02 NO NO20010569A patent/NO20010569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010072278A (ko) | 2001-07-31 |
| NO20010569D0 (no) | 2001-02-02 |
| CN1322138A (zh) | 2001-11-14 |
| NO20010569L (no) | 2001-04-04 |
| AUPP508798A0 (en) | 1998-08-27 |
| CA2339485A1 (en) | 2000-02-17 |
| JP2002522396A (ja) | 2002-07-23 |
| EP1102599A1 (de) | 2001-05-30 |
| EP1102599A4 (de) | 2004-03-17 |
| WO2000007620A1 (en) | 2000-02-17 |
| US6288025B1 (en) | 2001-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142908A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
| IL129603A0 (en) | Benzamidoaldehydes and their use as cysteine protease inhibitors | |
| IL151132A0 (en) | Pteridine compounds for the treatment of psoriasis | |
| PL349192A1 (en) | Protease inhibitors | |
| ZA200108413B (en) | Use of glycosyceramide synthesis inhibitors in therapy. | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| AU2002248269A1 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
| EP1093367A4 (de) | Proteaseinhibitoren | |
| IL127496A0 (en) | The use of MMP inhibitors for the treatment of ocular angiogenesis | |
| PL356784A1 (en) | Substances for use in treating psoriasis | |
| ZA975288B (en) | The use of TCET in the prophylaxis and treatment of allergies. | |
| GB9816234D0 (en) | Compounds for use in the treatment of inflammation | |
| EP1067894A4 (de) | Protheaseinhibitoren | |
| SI1197485T1 (en) | Cyclobuten-dione derivatives for use in the treatment of artherosclerosis | |
| EP1079821A4 (de) | Protease inhibitoren | |
| HUP0102880A2 (en) | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions | |
| IL141056A0 (en) | Protease inhibitors for use in the treatment of psoriasis | |
| IL138594A0 (en) | Use of protease inhibitors for treating skin wounds | |
| IL155769A0 (en) | Method for the treatment of inflammation | |
| EP1086083A4 (de) | Proteaseinhibitoren | |
| EP1140897A4 (de) | Protease inhibitoren | |
| AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
| GB9922710D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis | |
| HK1043938A1 (en) | Composition for the treatment of psoriasis | |
| AU2003204149A1 (en) | Protease inhibitors for use in the treatment of psoriasis |